| Literature DB >> 31760956 |
Elif Arslanoglu Aydin1, Selcan Demir2, Orkun Aydin3, Yelda Bilginer2, Seza Ozen4.
Abstract
BACKGROUND: Kawasaki disease is an acute, febrile vasculitis of childhood that affects medium-sized arteries, predominantly the coronary arteries. It is a multisystem disease; therefore, it may present with non-cardiac findings of disease. CASEEntities:
Keywords: Kawasaki disease; Pleural effusion; Pulmonary involvement
Mesh:
Substances:
Year: 2019 PMID: 31760956 PMCID: PMC6876070 DOI: 10.1186/s13256-019-2284-4
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Fig. 1Chest X-ray of the patient showing left lower lobar consolidation with pleural effusion
Fig. 2Study flowchart
Clinical symptoms and laboratory parameters of patients who had pulmonary involvement associated with Kawasaki disease
| Authors, year, reference number | Rash | Oral changes | Extremity changes | Red eyes | Adenitis | Other clinical symptoms | Hb (g/dL) | WBC (/mm3) | Plt (/mm3) | CRP (mg/dL) | ESR (mm/hour) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Singh | 5 | 1 | 8 | 1 | 0 | Perianal desquamation, 3 irritability, 1 | NA | 25,009 | 886,545 | 14.05 | 53.75 |
| Alhammadi and Hendaus, 2013, [ | NA | NA | NA | NA | NA | NA | NA | 24,000 | 600,000 | 10 | 65 |
| Lee | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Lee | Yes | Yes | Yes | Yes | Yes | Perianal desquamation | NA | 5500 | 178,000 | 2.8 | 21 |
| Falcini | No | No | No | Yes | No | Irritability | 9.5 | 21,800 | 710,000 | 27.8 | 99 |
| Elizabeth | No | Yes | Yes | No | Yes | Irritability | 10.2 | 12,800 | 550,000 | 7.7 | 86 |
| Yavuz | Yes | Yes | Yes | Yes | No | Non-pigmented keratic precipitates in both of the patient’s eyes, sterile pyuria | 10.4 | 32,800 | 734,000 | 21.8 | 90 |
| Sittiwangkul and Pongprot, 2004, [ | Yes | No | Yes | Yes | No | Irritability | NA | 21,200 | 231,000 | 4.77 | 66 |
| de Magalhães | Yes | Yes | Yes | Yes | No | Induration at the BCG site, perianal desquamation | 6.5 | 25,000 | 905,000 | 34 | 120 |
| Hamada | Yes | Yes | Yes | No | Yes | Hepatomegaly | NA | 17,800 | NA | 13.9 | NA |
| D'Souza | No | No | Yes | No | Yes | Sterile pyuria | 9.8 | 56,800 | 690,000 | NA | 138 |
| de Maddi | |||||||||||
| Case 1 | No | Yes | No | Yes | Yes | No | 8.7 | 11,200 | 561,000 | 10.4 | 70 |
| Case 2 | No | No | No | No | No | No | 9 | 26,960 | 142,000 | 40.8 | 107 |
| Case 3 | Yes | Yes | No | Yes | No | Irritability, sterile pyuria | 11 | 18,500 | 1,087,000 | 2.95 | 50 |
| Freeman | |||||||||||
| Case 1 | Yes | Yes | No | Yes | No | Irritability | NA | NA | 1,120,000 | NA | NA |
| Case 2 | No | Yes | No | Yes | Yes | Torticollis | NA | NA | 1,102,000 | NA | 114 |
| Case 3 | Yes | No | No | No | Yes | Anorexia | NA | NA | 450,000 | 10.5 | NA |
| Kobayashi | |||||||||||
| Case 1 | Yes | Yes | No | Yes | Yes | 9.6 | 13,000 | 321,000 | 12.6 | 102 | |
| Case 2 | Yes | Yes | Yes | Yes | No | Induration at the BCG site | 11.6 | 18,800 | 314,000 | 7.6 | NA |
| Vaidya | Yes | Yes | Yes | No | No | 8.9 | 15,600 | 567,000 | 5.6 | 40 | |
| Akagi | |||||||||||
| Case 1 | Yes | Yes | Yes | No | No | NA | NA | NA | 4.26 | NA | |
| Case 2 | Yes | Yes | No | No | No | NA | NA | NA | 4.32 | NA | |
aNumber of the patients who had the symptom
b,c,dValues are expressed as mean for 11, 8, and 10 patients, respectively
BCG Bacille Calmette–Guérin, CRP C-reactive protein, ESR erythrocyte sedimentation rate, Hb hemoglobin, NA not available, Plt platelet, WBC white blood cell
Demographic parameters and clinical presentations of patients who had pulmonary involvement associated with Kawasaki disease
| Authors, year, reference number | Patients ( | Sex | Age at onset of disease (months) | Initial symptoms | Fever duration (days) | Chest X-ray findings |
|---|---|---|---|---|---|---|
| Singh | 11 | F, 6 M, 5 | 30 | Fever, cough, tachypnea | 14.1 | Consolidation,11 empyema, 3 |
| Alhammadi and Hendaus, 2013, [ | 1 | F | 36 | Fever, cough, sore throat | 18 | Consolidation, pleural effusion |
| Lee | 54 | NA | NA | NA | NA | Reticulonodular,17 diffuse interstitial, 5 |
| Lee | 1 | M | 22 | Fever, cough, rhinorrhea | 6 | Infiltration, pleural effusion |
| Falcini | 1 | F | 30 | Fever, cough, | 12 | Pleural effusion |
| Elizabeth | 1 | F | 36 | Fever, gum bleeding | 21 | Pleural effusion |
| Yavuz | 1 | M | 11 | Fever, pharyngeal erythema, dyspnea | > 5 | Pleural effusion |
| Sittiwangkul and Pongprot, 2004, [ | 1 | F | 11 | Fever, jaundice, diarrhea, dyspnea | 15 | Pleural effusion |
| de Magalhães | 1 | F | 3 | Fever | 10 | Infiltration |
| Hamada | 1 | F | 60 | Fever, abdominal pain, knee joint pain | 15 | Pleural effusion |
| D'Souza | 1 | M | 5 | Fever, diarrhea, dyspnea | 7 | Pleural effusion |
| Case 1 | 1 | M | 8 | Fever, sore throat | 8 | Consolidation |
| Case 2 | 1 | F | 11 | Febrile seizure, sore throat, cough | 14 | Consolidation |
| Case 3 | 1 | F | 23 | Fever, cough | 10 | Consolidation |
| Freeman | ||||||
| Case 1 | 1 | M | 4 | Fever, cough, rash | 21 | NA |
| Case 2 | 1 | M | 6 | Fever | 60 | Normal; thorax CT, pulmonary nodule |
| Case 3 | 1 | NA | 5 | Fever cough, rash | 4 | Infiltration, multiple pulmonary nodules |
| Kobayashi | ||||||
| Case 1 | 1 | F | 24 | Fever, cracked lips, rash | 5 | Infiltration, pleural effusion |
| Case 2 | 1 | F | 24 | Fever, cough, nasal discharge | 4 | Atelectasis |
| Vaidya | 1 | F | 3 | Fever, rash, dyspnea | 32 | Hydropneumothorax, consolidation, pneumatoceles |
| Akagi | ||||||
| Case 1 | 1 | F | 4 | Fever, erythema of the lips, rash | NA | NA; thorax MRI, bilateral multiple pulmonary nodules |
| Case 2 | 1 | F | 5 | Fever, erythema of the lips, rash | 9 | Infiltration; thorax CT, bilateral pulmonary nodules |
aNumber of the patients who had noted findings
bValues are expressed as mean for 11 patients
CT computed tomography, F female, M male, MRI magnetic resonance imaging, NA not available
Treatment, coronary artery involvement, follow-up, and outcomes of patients who had pulmonary involvement associated with Kawasaki disease
| Authors, year, reference number | Infectious agent | Antibiotic treatment | CAI | Treatment | Follow-up and outcome |
|---|---|---|---|---|---|
| Singh | 2 | 11 | 3 | 2 | 9 |
| Alhammadi and Hendaus, 2013, [ | No | Yes | Yes | IVIG | Normal |
| Lee | NA | NA | NA | NA | NA |
| Lee | No | No | Yes | Second dose of IVIG and corticosteroid | Normal |
| Falcini | No | Yes | Yes | Second dose of IVIG and corticosteroid | Normal |
| Elizabeth | No | Yes | Yes | Second dose of IVIG and corticosteroid | Normal |
| Yavuz | No | Yes | Yes | Second dose of IVIG | Normal |
| Sittiwangkul and Pongprot, 2004, [ | No | Yes | Yes | Second dose of IVIG and corticosteroid | Aneurysm persisted in 2 years |
| de Magalhães | No | Yes | Yes | Second dose of IVIG, corticosteroid, MTX, and ETN | Aneurysm decrease but persisted |
| Hamada | No | Yes | No | Second dose of IVIG and corticosteroid | Normal |
| D'Souza | No | Yes | No | IVIG | Normal |
| de Maddi | |||||
| Case 1 | No | Yes | No | IVIG | Normal |
| Case 2 | No | Yes | No | Not given IVIG | Normal |
| Case 3 | No | Yes | No | IVIG | Normal |
| Freeman | |||||
| Case 1 | No | Yes | Yes | IVIG | Death |
| Case 2 | NA | Yes | Yes | IVIG | Normal |
| Case 3 | No | Yes | Yes | IVIG | Normal |
| Kobayashi | |||||
| Case 1 | Yes | Yes | NA | IVIG | Normal |
| Case 2 | Yes | Yes | NA | IVIG | Normal |
| Vaidya | No | Yes | Yes | IVIG | NA |
| Akagi | |||||
| Case 1 | No | No | Yes | IVIG | Normal |
| Case 2 | No | Yes | Yes | IVIG | Normal |
aNumber of the patients
CAI coronary artery involvement, ETN etanercept, IVIG intravenous immunoglobulin, MTX methotrexate, NA not available